By Kelly Cloonan
Odyssey Therapeutics has withdrawn the initial public offering it filed for in January.
The Boston-based biopharmaceutical company on Monday asked the Securities and Exchange Commission to retract the filing, which did not disclose an expected share price or the number of shares it planned to sell.
Odyssey said it had determined that it was not in its best interests to of the company to conduct an offering at this time.
The company had planned to list shares on the Nasdaq under the ticker ODTX.
Write to Kelly Cloonan at kelly.cloonan@wsj.com
(END) Dow Jones Newswires
June 09, 2025 17:16 ET (21:16 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。